These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 3117360)
1. In vivo antitumor effect of lymphokine-activated rodent polymorphonuclear leukocytes. Fujii Y; Kimura S; Arai S; Sendo F Cancer Res; 1987 Nov; 47(22):6000-5. PubMed ID: 3117360 [TBL] [Abstract][Full Text] [Related]
2. [Antitumor effect of OK-432 (3)--mechanisms of tumor growth inhibition by OK-432 induced activated macrophages]. Nanjo M; Saito M; Aonuma E; Fujimura H; Nakamura T; Aso H; Yoshie O; Ebina T; Ishida N Gan To Kagaku Ryoho; 1985 Apr; 12(4):887-93. PubMed ID: 3885861 [TBL] [Abstract][Full Text] [Related]
3. In vivo activity of lymphokine-activated macrophages in host defense against neoplasia. Fernandez-Cruz E; Ulich T; Schreiber RD J Immunol; 1985 May; 134(5):3489-96. PubMed ID: 3920323 [TBL] [Abstract][Full Text] [Related]
4. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level. Sensi M; Orosz CG; Bach FH J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778 [TBL] [Abstract][Full Text] [Related]
5. In vitro induction of cytotoxic polymorphonuclear leukocytes by supernatant from a concanavalin A-stimulated spleen cell culture. Inoue T; Sendo F J Immunol; 1983 Nov; 131(5):2508-14. PubMed ID: 6605388 [TBL] [Abstract][Full Text] [Related]
6. Effector mechanisms of syngeneic anti-tumour responses in mice. II. Cytotoxic T lymphocytes mediate neutralization and rejection of radiation-induced leukaemia RL male 1 in the nude mouse system. Keyaki A; Kuribayashi K; Sakaguchi S; Masuda T; Yamashita J; Handa H; Nakayama E Immunology; 1985 Sep; 56(1):141-51. PubMed ID: 3876272 [TBL] [Abstract][Full Text] [Related]
7. Macrophage tumoricidal activity as a possible antitumor mechanism associated with the local injection of allogeneic spleen cells into rats. Kawase I; Komuta K; Namba M; Yokota S; Ogura T; Kishimoto S Cancer Res; 1986 Mar; 46(3):1047-54. PubMed ID: 3510719 [TBL] [Abstract][Full Text] [Related]
8. Adoptive immunotherapy by pantropic killer cells recovered from OK-432-injected tumor sites in mice. Saito M; Nanjo M; Kataoka M; Moriya Y; Sugawara Y; Yoshida T; Ishida N Cancer Res; 1988 Aug; 48(15):4163-7. PubMed ID: 3390809 [TBL] [Abstract][Full Text] [Related]
9. Production of factor(s) that render polymorphonuclear leukocytes cytostatic from spleen cells stimulated with a streptococcal preparation, OK-432. Kimura S; Inoue T; Yamashita T; Midorikawa Y; Arai S; Sendo F Cancer Res; 1987 Dec; 47(23):6204-9. PubMed ID: 3315182 [TBL] [Abstract][Full Text] [Related]
10. Activation of cytotoxic polymorphonuclear leukocytes by in vivo administration of a streptococcal preparation, OK-432. Watabe S; Sendo F; Kimura S; Arai S J Natl Cancer Inst; 1984 Jun; 72(6):1365-70. PubMed ID: 6587156 [TBL] [Abstract][Full Text] [Related]
11. [Anticancer effects of OK-432 (2). Anticancer actions of M phi activated by OK-432]. Saito M; Aonuma E; Noda T; Nakadate I; Nanjo M; Ebina T; Ishida N Gan To Kagaku Ryoho; 1983 May; 10(5):1363-71. PubMed ID: 6870302 [TBL] [Abstract][Full Text] [Related]
12. Studies of the immune response against a polyoma virus-induced fibrosarcoma in BALB mice using the Winn's tumor neutralization assay. de Lapeyrière O; Imbert J; Cot E; Meyer G Bull Cancer; 1981; 68(2):101-8. PubMed ID: 6263382 [TBL] [Abstract][Full Text] [Related]
13. Synergistic therapeutic effect of combination therapy with OK-432 and interferon-alpha or -gamma on Meth-A ascites tumor in BALB/c mice. Mizushima Y; Morikage T; Hirata H; Sato M; Sakamoto K; Yano S J Biol Response Mod; 1988 Aug; 7(4):371-83. PubMed ID: 3139841 [TBL] [Abstract][Full Text] [Related]
14. Augmentation by OK-432 of generation of culture-induced killer cells. Ujiie T Jpn J Exp Med; 1987 Jun; 57(3):153-61. PubMed ID: 3682231 [TBL] [Abstract][Full Text] [Related]
15. Tumor cell surface expression of granulocyte-macrophage colony-stimulating factor elicits antitumor immunity and protects from tumor challenge in the P815 mouse mastocytoma tumor model. Soo Hoo W; Lundeen KA; Kohrumel JR; Pham NL; Brostoff SW; Bartholomew RM; Carlo DJ J Immunol; 1999 Jun; 162(12):7343-9. PubMed ID: 10358185 [TBL] [Abstract][Full Text] [Related]
16. [Induction of LAK cells in peritoneal cavity of mice after ip injection of OK-432 and antitumor effect of these LAK cells]. Ishida N; Saito M; Nanjo M Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2681-90. PubMed ID: 6508321 [TBL] [Abstract][Full Text] [Related]
17. In vivo transfer of antitumor activity by peritoneal exudate cells from mice treated with C. parvum. Peters LJ; McBride WH; Mason KA; Hunter N; Basíc I; Milas L Dev Biol Stand; 1977 Apr 13-15; 38():297-300. PubMed ID: 608514 [TBL] [Abstract][Full Text] [Related]
18. Antitumor mechanisms of Z-100, an immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis: the importance of lymphocytes infiltrated into tumor sites. Sasaki H; Schmitt D; Hayashi Y; Pollard RB; Suzuki F Nat Immun; 1993; 12(2):104-12. PubMed ID: 8318815 [TBL] [Abstract][Full Text] [Related]
19. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study. Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805 [TBL] [Abstract][Full Text] [Related]
20. Activation of nonspecific killer cells by interleukin 2-containing supernatants. Teh HS; Yu M J Immunol; 1983 Oct; 131(4):1827-33. PubMed ID: 6194216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]